{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["BRIGHAM AND WOMEN'S HOSPITAL"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA755359"],"scientific_name":["Homo sapiens"],"long_description":["A rapid, sensitive, low-cost diagnostic device for early detection of novel Coronavirus Disease (COVID-19) could significantly change the paradigm in real-time and efficient management of patients and available healthcare resources, specifically during this time of increased demand for hospital services. The quantitative real-time polymerase chain reaction (qPCR) represents the most important method for the diagnosis of COVID-19 at its early stage of infection and before the appearance of clinical symptoms. However, qPCR-based molecular diagnostics are bulky, expensive, lab-based, and require trained personnel for system operation. The majority of the FDA EUA-approved COVID-19 diagnostics are PCR-based, which require nucleic acid extraction, followed by amplification via thermal cycling... (for more see dbGaP study page.)"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Rapid, Sensitive, Point-of- care, Antigen-based Diagnostics for SARS-CoV-2","description":"Rapid Acceleration of Diagnostics - Radical (RADx-rad): A Rapid, Sensitive, Point-of- care, Antigen-based Diagnostics for SARS-CoV-2","dates":{"last_updated":"2025-09-24","first_public":"2022-11-24"},"accession":"PRJNA755359","cross_references":{"taxon":["9606"]}}